Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
287 | 3 | NEUROSCIENCES//PLACE CELLS//NICOTINIC RECEPTORS | 43018 |
2479 | 2 | MUSCARINIC RECEPTORS//XANOMELINE//MUSCARINIC RECEPTOR SUBTYPES | 4194 |
17924 | 1 | M 1//XANOMELINE//VANDERBILT NEUROSCI DRUG DISCOVERY | 602 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | M 1 | authKW | 699958 | 3% | 70% | 19 |
2 | XANOMELINE | authKW | 563086 | 3% | 51% | 21 |
3 | VANDERBILT NEUROSCI DRUG DISCOVERY | address | 464856 | 7% | 20% | 44 |
4 | M 4 | authKW | 353373 | 1% | 75% | 9 |
5 | MUSCARINIC | authKW | 340977 | 10% | 11% | 62 |
6 | M 5 | authKW | 335051 | 1% | 80% | 8 |
7 | MUSCARINIC ACETYLCHOLINE RECEPTOR 1 | authKW | 320656 | 1% | 88% | 7 |
8 | REBECCA L COOPER S | address | 287905 | 4% | 25% | 22 |
9 | NEUROSCI INNOVAT MED | address | 285026 | 1% | 78% | 7 |
10 | POSITIVE ALLOSTERIC MODULATOR PAM | authKW | 285012 | 2% | 39% | 14 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Neurosciences | 2808 | 40% | 0% | 242 |
2 | Psychiatry | 2681 | 25% | 0% | 148 |
3 | Pharmacology & Pharmacy | 2596 | 39% | 0% | 234 |
4 | Chemistry, Medicinal | 1827 | 17% | 0% | 101 |
5 | Clinical Neurology | 395 | 12% | 0% | 75 |
6 | Chemistry, Organic | 197 | 10% | 0% | 58 |
7 | Biochemistry & Molecular Biology | 42 | 12% | 0% | 70 |
8 | Behavioral Sciences | 28 | 2% | 0% | 12 |
9 | Medicine, Research & Experimental | 10 | 3% | 0% | 17 |
10 | Substance Abuse | 6 | 1% | 0% | 4 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | VANDERBILT NEUROSCI DRUG DISCOVERY | 464856 | 7% | 20% | 44 |
2 | REBECCA L COOPER S | 287905 | 4% | 25% | 22 |
3 | NEUROSCI INNOVAT MED | 285026 | 1% | 78% | 7 |
4 | MOL PSYCHIAT S | 261761 | 1% | 100% | 5 |
5 | VANDERBILT NEUROSCIENCE DRUG DISCOVERY | 157057 | 0% | 100% | 3 |
6 | VANDERBILT PROGRAM DRUG DISCOVERY | 134991 | 2% | 18% | 14 |
7 | SUMNEYTOWN PIKE | 104705 | 0% | 100% | 2 |
8 | VANDERBILT PROGRAM DRUG DISCOVERYVANDERBILT SPEC | 104705 | 0% | 100% | 2 |
9 | MOL SIGNALING SECT | 84493 | 3% | 9% | 17 |
10 | DRUG DISCOVERY BIOL | 73609 | 3% | 9% | 16 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ACS CHEMICAL NEUROSCIENCE | 15906 | 3% | 2% | 18 |
2 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 4832 | 8% | 0% | 49 |
3 | INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 4822 | 2% | 1% | 13 |
4 | NEUROPSYCHOPHARMACOLOGY | 2568 | 3% | 0% | 16 |
5 | MOLECULAR PHARMACOLOGY | 2322 | 3% | 0% | 21 |
6 | SCHIZOPHRENIA RESEARCH | 1948 | 2% | 0% | 15 |
7 | CLINICAL NEUROPHARMACOLOGY | 1737 | 1% | 0% | 9 |
8 | PSYCHOPHARMACOLOGY | 1683 | 3% | 0% | 20 |
9 | CURRENT NEUROPHARMACOLOGY | 1429 | 1% | 1% | 4 |
10 | ACS MEDICINAL CHEMISTRY LETTERS | 1264 | 1% | 0% | 6 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | M 1 | 699958 | 3% | 70% | 19 | Search M+1 | Search M+1 |
2 | XANOMELINE | 563086 | 3% | 51% | 21 | Search XANOMELINE | Search XANOMELINE |
3 | M 4 | 353373 | 1% | 75% | 9 | Search M+4 | Search M+4 |
4 | MUSCARINIC | 340977 | 10% | 11% | 62 | Search MUSCARINIC | Search MUSCARINIC |
5 | M 5 | 335051 | 1% | 80% | 8 | Search M+5 | Search M+5 |
6 | MUSCARINIC ACETYLCHOLINE RECEPTOR 1 | 320656 | 1% | 88% | 7 | Search MUSCARINIC+ACETYLCHOLINE+RECEPTOR+1 | Search MUSCARINIC+ACETYLCHOLINE+RECEPTOR+1 |
7 | POSITIVE ALLOSTERIC MODULATOR PAM | 285012 | 2% | 39% | 14 | Search POSITIVE+ALLOSTERIC+MODULATOR+PAM | Search POSITIVE+ALLOSTERIC+MODULATOR+PAM |
8 | BQCA | 269239 | 1% | 86% | 6 | Search BQCA | Search BQCA |
9 | M 4 MUSCARINIC ACETYLCHOLINE RECEPTOR | 218133 | 1% | 83% | 5 | Search M+4+MUSCARINIC+ACETYLCHOLINE+RECEPTOR | Search M+4+MUSCARINIC+ACETYLCHOLINE+RECEPTOR |
10 | AF150S | 167526 | 1% | 80% | 4 | Search AF150S | Search AF150S |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |